ID   WEHI-3B/CTRES
AC   CVCL_4Y52
SY   WEHI-3B/CT/REV
DR   Wikidata; Q54993765
RX   PubMed=12083375;
RX   PubMed=16541129;
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4357 ! WEHI-3B D+
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 5
//
RX   PubMed=12083375; DOI=10.1023/A:1015593226414;
RA   Pessina A., Giuliani A., Croera C., Foti P., Mascolo L., Gagliardi G.,
RA   Neri M.G.;
RT   "Selection of a WEHI-3B leukemia cell subclone resistant to inhibition
RT   by cholera toxin.";
RL   Mol. Cell. Biochem. 233:19-26(2002).
//
RX   PubMed=16541129; DOI=10.1038/sj.cr.7310038;
RA   Pessina A., Croera C., Savalli N., Bonomi A., Cavicchini L.,
RA   Turlizzi E., Guizzardi F., Guido L., Daprai L., Neri M.G.;
RT   "Bcl-2 down modulation in WEHI-3B/CTRES cells resistant to Cholera
RT   Toxin (CT)-induced apoptosis.";
RL   Cell Res. 16:306-312(2006).
//